Long-term trends in total administered radiation dose from brain [18F]FDG-PET in children with drug-resistant epilepsy
European Journal of Nuclear Medicine and Molecular Imaging · 2025
DOI: 10.1007/s00259-024-06902-8 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Nuclear Medicine and Molecular Imaging, 2025. Verfasst von Antonio G Gennari und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nuclear Medicine, University Hospital Zurich, Rämistrasse 100, CH-8091, Zurich, Switzerland. Hauptthemen laut MEDLINE: Fluorodeoxyglucose F18, Radiation Dosage, Brain, Drug Resistant Epilepsy. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: CRPP AI Oncological Imaging Network of the University of Zurich, Palatin Stiftung, Anna Mueller Grocholski Foundation, Switzerland.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Purpose
To assess the trends in administered 2-[ 18 F]fluoro-2-deoxy-D-glucose ([ 18 F]FDG) doses, computed tomography (CT) radiation doses, and image quality over the last 15 years in children with drug-resistant epilepsy (DRE) undergoing hybrid positron emission tomography (PET) brain scans.
Methods
We retrospectively analyzed data from children with DRE who had [ 18 F]FDG-PET/CT or magnetic resonance scans for presurgical evaluation between 2005 and 2021. We evaluated changes in injected [ 18 F]FDG doses, administered activity per body weight, CT dose index volume (CTDIvol), and dose length product (DLP). PET image quality was assessed visually by four trained raters. Conversely, CT image quality was measured using region-of-interest analysis, normalized by signal-to-noise (SNR) and contrast-to-noise ratio (CNR).
Results
We included 55 children (30 male, mean age: 9 ± 6 years) who underwent 61 [ 18 F]FDG-PET scans (71% as PET/CT). Annually, the injected [ 18 F]FDG dose decreased by ~ 1% (95% CI: 0.92%-0.98%, p < 0.001), with no significant changes in administered activity per body weight (p = 0.51). CTDIvol and DLP decreased annually by 16% (95% CI: 9%-23%) and 15% (95% CI: 8%-21%, both p < 0.001), respectively. PET image quality improved by 9% year-over-year (95% CI: 6%-13%, p < 0.001), while CT-associated SNR and CNR decreased annually by 7% (95% CI: 3%-11%, p = 0.001) and 6% (95% CI: 2%-10%, p = 0.008), respectively.
Conclusion
Our findings indicate stability in [ 18 F]FDG administered activity per body weight alongside improvements in PET image quality. Conversely, CT-associated radiation doses reduced. These results reaffirm [ 18 F]FDG-PET as an increasingly safer and higher-resolution auxiliary imaging modality for children with DRE. These improvements, driven by technological advancements, may enhance the diagnostic precision and patient outcomes in pediatric epilepsy surgery.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nuclear Medicine, University Hospital Zurich, Rämistrasse 100, CH-8091, Zurich, Switzerland.
- University of Zurich, Zurich, Switzerland.
- Department of Neuropediatrics, University Children's Hospital of Zurich, Steinwiesstrasse 75, CH-8032, Zurich, Switzerland.
- MR-Research Centre, University Children's Hospital of Zurich, Steinwiesstrasse 75, CH-8032, Zurich, Switzerland.
- Department of Radiology and Nuclear Medicine, Children's Hospital of Eastern Switzerland, St. Gallen, Switzerland.
- Children's Research Centre, University Children's Hospital of Zurich, Zurich, Switzerland.
ORCID-Profile: Antonio G Gennari, Stephan Waelti, Moritz Schwyzer, Valerie Treyer, Alexia Rossi, Thomas Sartoretti, Alexander Maurer, Georgia Ramantani, Ruth Tuura O'Gorman, Christian J Kellenberger, Martin W Hüllner, Michael Messerli
Förderung
- CRPP AI Oncological Imaging Network of the University of Zurich
- Palatin Stiftung
- Anna Mueller Grocholski Foundation, Switzerland
- Swiss Government Excellence Scholarship, Switzerland
- Premio Nino ed Hansi Cominotti, Italy
- GE Healthcare
- Theodor und Ida Herzog-Egli-Stiftung
- University of Zurich
Zitieren
APA
Gennari, A. G., Waelti, S., Schwyzer, M., Treyer, V., Rossi, A., Sartoretti, T., Maurer, A., Ramantani, G., Tuura O'Gorman, R., Kellenberger, C. J., Hüllner, M. W., & Messerli, M. (2025). Long-term trends in total administered radiation dose from brain [18F]FDG-PET in children with drug-resistant epilepsy. European Journal of Nuclear Medicine and Molecular Imaging. https://doi.org/10.1007/s00259-024-06902-8
Vancouver
Gennari AG, Waelti S, Schwyzer M, Treyer V, Rossi A, Sartoretti T, et al. Long-term trends in total administered radiation dose from brain [18F]FDG-PET in children with drug-resistant epilepsy. European Journal of Nuclear Medicine and Molecular Imaging. 2025. doi:10.1007/s00259-024-06902-8
BibTeX
@article{Gennari2025,
author = {Gennari, Antonio G and Waelti, Stephan and Schwyzer, Moritz and Treyer, Valerie and Rossi, Alexia and Sartoretti, Thomas and Maurer, Alexander and Ramantani, Georgia and Tuura O'Gorman, Ruth and Kellenberger, Christian J and Hüllner, Martin W and Messerli, Michael},
title = {Long-term trends in total administered radiation dose from brain [18F]FDG-PET in children with drug-resistant epilepsy},
journal = {European Journal of Nuclear Medicine and Molecular Imaging},
year = {2025},
doi = {10.1007/s00259-024-06902-8}
}
EUVIMED